Page last updated: 2024-08-23

stearoylethanolamide and Carcinoma, Pancreatic Ductal

stearoylethanolamide has been researched along with Carcinoma, Pancreatic Ductal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barassi, A; Ciuffreda, P; Melzi d'Eril, G; Ottria, R; Pezzilli, R; Ravelli, A1

Other Studies

1 other study(ies) available for stearoylethanolamide and Carcinoma, Pancreatic Ductal

ArticleYear
Serum endocannabinoids in assessing pain in patients with chronic pancreatitis and in those with pancreatic ductal adenocarcinoma.
    Scandinavian journal of gastroenterology, 2017, Volume: 52, Issue:10

    Topics: Abdominal Pain; Adolescent; Adult; Aged; Aged, 80 and over; Amides; Arachidonic Acids; Cancer Pain; Carcinoma, Pancreatic Ductal; Case-Control Studies; Endocannabinoids; Ethanolamines; Female; Humans; Linoleic Acids; Male; Middle Aged; Oleic Acids; Pain Measurement; Palmitic Acids; Pancreatic Neoplasms; Pancreatitis, Chronic; Polyunsaturated Alkamides; Predictive Value of Tests; ROC Curve; Stearic Acids; Young Adult

2017